The #FDA -approved #AI algorithm called ProFound AI was more likely to show a false-positive cancer diagnosis in the mammograms of Black women, when compared to White, Hispanic or Asian women, new research shows. #BreastCancer
managedhealthcareexecutive.com/view/fda-appro…

Explore the depths of insight in May's MHE issue!

Click the link to immerse yourself in the engaging content and stay informed about the latest trends and ideas. Click Now!

bit.ly/3QWGR2r

In this Population Health Perspectives, David Hines analyzes the limited access to healthcare services on the health outcomes of individuals with diabetes. For more insight into diabetes management, watch the full series here: bit.ly/44URc4A #ManagedCare

Researchers from a study found that the program called the Adolescent Vaccination Program (AVP), raised vaccination rates from 64.7% to 80.2%. #HPV
managedhealthcareexecutive.com/view/uthealth-…

Editors spoke with Endeavor BioMedicines CEO John Hood about ENV-101, a novel Hedgehog inhibitor, in which he shared ENV-101 offers improved tolerability with fewer severe muscle spasms compared to FDA approved drugs. #ATS2024
managedhealthcareexecutive.com/view/the-poten…

New evidence suggests the use of #hormone replacement therapy (HRT) may lead to benefits in certain women with pulmonary #hypertension . The findings add to a long debate over the role of hormones like estrogen in the course of the disease.
managedhealthcareexecutive.com/view/hormone-r…

❗Today is the last day to submit❗MHE is seeking diverse early/mid-career healthcare professionals (<10 yrs exp) for our annual feature. Winners featured in our August issue, get passes to PBMI Annual Meeting in Orlando & more! #healthcare #opportunity
managedhealthcareexecutive.com/view/2024-emer…

Patients with more advanced pulmonary arterial #hypertension incur higher costs overall, according to a poster at the annual ATS meeting. #ATS2024 #PAH
managedhealthcareexecutive.com/view/majority-…

Tomorrow is your last day to submit❗ MHE is seeking diverse early/mid-career healthcare professionals (<10 yrs exp) for our annual feature. Winners featured in our August issue, get passes to PBMI Annual Meeting in Orlando & more! #healthcare #opportunity
managedhealthcareexecutive.com/view/2024-emer…

Using a race-neutral assessment of lung function test would reclassify 428,000 more Black patients as having moderate-to-severe chronic pulmonary and move Black and Asian patients up on the lung transplant list. #ATS2024
managedhealthcareexecutive.com/view/how-switc…

Results from a phase 2a study suggest that the benefits of Tezspire (tezepelumab) for people with chronic pulmonary obstructive disease may be limited to those with elevated blood eosinophil counts indicative of type 2 inflammation. #ATS2024
managedhealthcareexecutive.com/view/tezspire-…

Disparities in outcomes between Black and White children with acute myeloid leukemia may be due to differences in pharmacogenomics, which is how genes affect drug responses, according to a new study in JAMA Network Open.
managedhealthcareexecutive.com/view/the-role-…

Breast cancer stats from the American Association for Cancer Research 2024 Cancer Disparities Report. #BreastCancer
managedhealthcareexecutive.com/view/aacr-canc…

Tezspire is suggested as safe and efficacious in people whose COPD is fueled, in part, by type 2 inflammation, according to results of an analysis.
managedhealthcareexecutive.com/view/tezspire-…

Just launched!
Lawrence Eichenfield, M.D., discusses the landscape of #AtopicDermatitis (AD) care and the latest innovations in this space, as well as gaps in knowledge and areas of unmet need. Watch the K-Cast to learn about the evolution of AD care: bit.ly/3V8OQvC

Surya Bhatt, M.D., M.S.P.H., left, after presenting positive results from the NOTUS study of Dupixent as a treatment for a subgroup of people with COPD with high blood eosinophil counts indicative of type 2 inflammation. #ATS #ATS 2024

Poster area was busy & buzzy at 2024 ATS meeting today n San Diego today. Twas nice and old school: Researchers in front of their pinned posters, talking about study design & outcomes #2024ATS

Matthew DeCamp, M.D., Ph.D., of the University of Colorado, takes questions after presenting at the keynote session on artificial intelligence. DeCamp discussed bias in AI. #ATS2024

Less than a week away from our deadline to submit❗ MHE seeks diverse early/mid-career healthcare professionals (<10 yrs exp) for our feature. Winners featured in August issue, get passes to PBMI Annual Meeting in Orlando & more! #healthcare #opportunity
managedhealthcareexecutive.com/view/2024-emer…

Research published in JAMA Health Forum shows that #biosimilar savings have not trickled down to out-of-pocket savings for patients.
managedhealthcareexecutive.com/view/so-far-bi…